ViSi Mobile Monitoring System
FDA 510(k)Class II (US FDA 510(k))
Identifiers
- 510(k) Number
- K122036 FDA 510(k)
- FDA Product Code
- MWI FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 870.2300 FDA 510(k)
- Regulation Number
- 870.2300 FDA 510(k)
- Advisory Committee
- Cardiovascular FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
The ViSi Mobile Monitoring System is a wireless patient monitoring device designed for real-time tracking of vital signs. Classified under product code MWI, it is intended for continuous monitoring of patients in various settings, including in-bed, transport, and ambulatory environments. This system facilitates remote observation of physiological parameters, enabling clinicians to maintain oversight of patient status without direct physical presence.
The device is supplied as a reusable system, requiring adherence to manufacturer guidelines for cleaning and disinfection. It is intended for use in clinical environments and has received FDA clearance under 510(k) number K122036, with a decision classified as substantially equivalent under the Cardiovascular advisory committee. Storage and maintenance protocols must follow regulatory and manufacturer recommendations to ensure proper functionality and patient safety.
Frequently asked questions
What environments is the ViSi Mobile Monitoring System designed for?
The ViSi Mobile Monitoring System is specifically engineered for continuous patient monitoring in dynamic clinical settings, including in-bed patient care, transport scenarios (such as between wards or to imaging), and ambulatory environments where patients are moving freely. Its wireless design ensures flexibility, allowing clinicians to track vital signs without physical proximity, which is particularly useful in high-mobility or high-acuity areas like emergency departments, operating rooms, or post-procedure recovery zones.
How is the ViSi Mobile Monitoring System supplied, and what cleaning requirements apply?
The ViSi Mobile Monitoring System is supplied as a reusable device, meaning it is intended for repeated use across multiple patients. To maintain sterility and functionality, it must undergo thorough cleaning and disinfection following the manufacturer’s established protocols. These protocols are critical to prevent cross-contamination and ensure reliable performance, particularly in clinical environments where hygiene standards are paramount. Always refer to the manufacturer’s guidelines for specific cleaning agents, methods, and frequency.
Is the ViSi Mobile Monitoring System single-use or reusable, and how does this affect its use?
The ViSi Mobile Monitoring System is designed for reuse, not single-use. This distinction is important because reusable devices require rigorous maintenance procedures—including cleaning, disinfection, and potentially sterilization—to ensure safety and accuracy between patients. Reusability also extends the device’s lifespan and cost-effectiveness for healthcare facilities, provided proper protocols are strictly followed to mitigate infection risks and preserve functionality.
What regulatory approval does the ViSi Mobile Monitoring System hold, and how does this impact its use?
The ViSi Mobile Monitoring System has received FDA clearance under the 510(k) process, with a decision classified as substantially equivalent to a predicate device. This clearance indicates that the FDA has determined the system meets applicable safety and performance standards for its intended use in monitoring physiological parameters. Clinicians and facilities should adhere to the manufacturer’s instructions and regulatory guidelines to ensure compliance with FDA requirements, particularly regarding maintenance, calibration, and patient monitoring protocols.
What types of vital signs can the ViSi Mobile Monitoring System track in real time?
While the provided data does not specify exact physiological parameters, the ViSi Mobile Monitoring System is designed for continuous tracking of critical vital signs commonly monitored in clinical settings. These typically include heart rate, blood pressure, oxygen saturation (SpO₂), respiratory rate, and sometimes ECG or temperature, depending on the configuration. The wireless nature of the system enables seamless data transmission to a central monitoring station, allowing clinicians to remotely assess patient stability and intervene promptly if deviations occur.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Sotera Wireless ViSi Mobile: Patient Monitoring | RKS, SOTERA VISI USER MANUAL Pdf Download | ManualsLib, ViSi Mobile Vital Signs Monitoring System - medical-xprt.com, VISI Überblick - Hexagon Production Software
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K122036 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Sotera Wireless, Inc.
Sources (1)
- FDA 510(k) K122036 24 fields · synced Oct 1, 2026